Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea
- DOI
- 10.3346/jkms.2024.39.e8
- Published
- 2024
- Container
- Journal of Korean Medical Science
- Publisher
- XMLink
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3346/jkms.2024.39.e8,
title = {Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea},
author = {Eui-Soon Kim and Sun-Kyeong Park and Jong-Chan Youn and Hye Sun Lee and Hae-Young Lee and Hyun-Jai Cho and Jin-Oh Choi and Eun-Seok Jeon and Sang Eun Lee and Min-Seok Kim and Jae-Joong Kim and Kyung-Kuk Hwang and Myeong-Chan Cho and Shung Chull Chae and Seok-Min Kang and Jin Joo Park and Dong-Ju Choi and Byung-Su Yoo and Jae Yeong Cho and Kye Hun Kim and Byung-Hee Oh and Barry Greenberg and Sang Hong Baek},
year = {2024},
journal = {Journal of Korean Medical Science},
doi = {10.3346/jkms.2024.39.e8},
url = {https://doi.org/10.3346/jkms.2024.39.e8}
}RIS
TY - JOUR TI - Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea AU - Eui-Soon Kim AU - Sun-Kyeong Park AU - Jong-Chan Youn AU - Hye Sun Lee AU - Hae-Young Lee AU - Hyun-Jai Cho AU - Jin-Oh Choi AU - Eun-Seok Jeon AU - Sang Eun Lee AU - Min-Seok Kim AU - Jae-Joong Kim AU - Kyung-Kuk Hwang AU - Myeong-Chan Cho AU - Shung Chull Chae AU - Seok-Min Kang AU - Jin Joo Park AU - Dong-Ju Choi AU - Byung-Su Yoo AU - Jae Yeong Cho AU - Kye Hun Kim AU - Byung-Hee Oh AU - Barry Greenberg AU - Sang Hong Baek PY - 2024 JO - Journal of Korean Medical Science DO - 10.3346/jkms.2024.39.e8 UR - https://doi.org/10.3346/jkms.2024.39.e8 ER -
APA
Kim, E., Park, S., Youn, J., Lee, H. S., Lee, H., Cho, H., Choi, J., Jeon, E., Lee, S. E., Kim, M., Kim, J., Hwang, K., Cho, M., Chae, S. C., Kang, S., Park, J. J., Choi, D., Yoo, B., Cho, J. Y., Kim, K. H., Oh, B., Greenberg, B., & Baek, S. H. (2024). Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2024.39.e8
Source records
- crossref · retrieved 2026-09-25T19:09:17.750Z